Page 2891 - Cote clinical veterinary advisor dogs and cats 4th

1538 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.

Hypokalemic periodic paralysis, 684.e2 Ileum, surgical resection of, and cobalamin deficiency, Immunotherapy
183
Hypolactation, 570 Ileus, 1243 allergic-specific, for atopic dermatitis, 93
for feline leukemia virus, 331
Hypoluteoidism, abortion and, 3
VetBooks.ir Hypomagnesemia, 1364 Ilial fracture. See Pelvic fracture for mammary gland neoplasia, 622
Imaging. See specific imaging techniques
causes of, 1240
for oral tumors, malignant, 714–715
for pyoderma, 853
Imepitoin, 302
in diabetic ketoacidosis, 255
refeeding syndrome and, 871.e2
Imferon. See Iron-dextran injection
Hypomyelination, 994 Imerslund-Gräsbeck syndrome, 183 Imodium. See Loperamide
Impacted teeth. See Unerupted teeth
Hyponatremia, 518–519 IMHA. See Immune-mediated hemolytic anemia (IMHA) Impaction, anal sac, 53–54
causes of, 1241 Imidacloprid. See also Moxidectin-imidacloprid Impavido. See Miltefosine
syndrome of inappropriate antidiuretic hormone for demodicosis, 246 Impetigo, 851
secretion and, 955.e2 for pediculosis, 768 Impulse-control aggression, 40–42
Hyponatremic encephalopathy, 1047.e1 Imidacloprid-moxidectin. See Moxidectin-imidacloprid Imuran. See Azathioprine
Hypoosmolality, 1382 Imidacloprid-permethrin, for tick control, 978.e3 Inappetence. See Anorexia
Hypoparathyroidism Imidazoline decongestants toxicosis, 240–241 Inappropriate elimination. See also Behavioral assessment
management of, 1429.e1a Imidocarb in cats, 533–535, 1430.e2a–1430.e4a
primary, 519–521 administration and dosage of, 1484 in dogs, 535–537
Hypophosphatemia for babesiosis, 106 Incidentaloma, 34–35
causes of, 1241 for cytauxzoonosis, 236 Incisive bones, 180
in diabetes mellitus, 253.e3 for hepatozoonosis, 462 Inclusion cyst, 228.e2, 228.e2f–228.e3f
in diabetic ketoacidosis, 255 Imipenem, for hepatobiliary infections and abscesses, 456 Incontinence
hemolytic anemia and, 59 Imipenem-cilastatin, 1484 fecal, 537–538, 1245–1246
refeeding syndrome and, 871.e2 Imipramine urinary, 538–539, 1184.e2
Hypopigmentation, 195–197 administration and dosage of, 1484 causes of, 1246
Hypoplastic trachea, 129, 521–522 toxicosis from, 72 estrogen-responsive, 1011
Hypoproteinemia, 1387 Imiquimod Incoordination. See Ataxia
Hypopyon, 522–523 for papillomas, 753 Increased intracranial pressure, 1080
Hyposensitization, 299 squamous cell carcinoma and, 941 Indanedione. See Anticoagulant rodenticides
Hyposomatotropism. See Alopecia X; Pituitary dwarfism Imizole. See Imidocarb Inderal. See Propranolol
Hypospadias, 523.e2–523.e3, 523.e2f–523.e3f Immiticide. See Melarsomine Indian common mallow, 463t–464t
Hypotension, systemic, 523.e3–523.e5, 1242 Immotile cilia syndrome, 174.e2. See also Primary ciliary Indolent corneal ulcer, 209–211, 210f
Hypothalamic kindling, 39 dyskinesia Indolent ulcer. See Eosinophilic granuloma complex
Hypothermia, 523–524 Immune hypersensitivity, type 1. See Anaphylaxis Indomethacin toxicosis, 696
causes of, 1242 Immune-mediated disorders Inducible cough, in bronchiectasis, 133
head trauma treated with, 406 fever of unknown origin and, 1223–1225 Inductive fibroameloblastoma, 712
peritoneal dialysis and, 1151.e2 pannus and, 748–749 Indwelling urinary catheter care, 1182–1183, 1183.e1f
rewarming for, 524 pinnal disease and, 790 Infarction
Hypothermic injury. See Frostbite pododermatitis and, 799 brain. See Encephalopathy, vascular
Hypothyroidism, 525–527 polyarthritis and, 803 splenic, 935
alopecia and, 1196 polymyositis, 807.e2 Infections
congenital, 525, 946 uveitis and, 1024 localized, fever of unknown origin and, 1223–1225
myasthenia gravis and, 669 Immune-mediated erosive polyarthritis. See Rheumatoid opportunistic, 671.e2–671.e3
neurologic associations, 1242 arthritis Infectious canine hepatitis. See Canine infectious hepatitis
pituitary dwarfism and, 790.e2 Immune-mediated hemolytic anemia (IMHA), 60–63, (CIH)
stunted growth and, 946 62f, 62.e1f Infectious diseases
treatment of, 1429.e2a Immune-mediated neutropenia, 693.e2–693.e3 fever of unknown origin and, 1223–1225
Hypotonic fluid loss, hypernatremia and, Immune-mediated polyarthritis, 803 granulomatous enteritis/colitis and, 395
498–499 Immune-mediated polymyositis, 807.e2 hemolytic anemia and, 59–60
Hypotonic urinary bladder, 89–91 Immune-mediated rhinitis. See Lymphoplasmacytic polyarthritis and, 803
Hypotrichosis. See Alopecia rhinitis renomegaly and, 879.e4
Hypoventilation, 527–528 Immune-mediated thrombocytopenia, 972–973 vasculitis and, 1031.e4
Hypovitaminosis C. See Hypertrophic osteodystrophy Immune modulators. See Immunotherapy Infectious hepatitis, canine. See Canine infectious
(HOD) Immunization. See Vaccination hepatitis (CIH)
Hypovolemia, 1382–1383 Immunodeficiency syndromes Infectious peritonitis, feline. See Feline infectious
Hypovolemic shock, 911–912, 1449a acquired, causes of, 1243 peritonitis (FIP)
Hypoxemia. See also Cyanosis congenital, 1244 Infectious tracheobronchitis, canine, 987–989, 989.e1f
causes of, 1242 in dogs, 531–533 Infective endocarditis, 294–296
respiratory alkalosis and, 1195 Immunodeficiency virus, feline. See Feline Infecundity. See Infertility
Hypoxia, and lactic acidosis, 1192 immunodeficiency virus (FIV) Infertility, 1247. See also Breeding soundness exam
Hytakerol. See Dihydrotachysterol (DHT) Immunoglobulin brucellosis and, 138.e4
administration and dosage of, 1484 female dog, 539–541, 1430a
I for erythema multiforme and toxic epidermal male, 541–543, 542f, 1247
I-cell disease, 945.e2–945.e3 necrolysis, 309.e3 Infiltrative anesthesia, 1129–1130
IBD. See Inflammatory bowel disease (IBD) for immune-mediated thrombocytopenia, 973 Inflammatory arthropathies, 1384
Ibuprofen toxicosis, 696 for polyradiculoneuritis, 811 Inflammatory bowel disease (IBD), 395, 543–545.
Ichthyosis, 214, 216 Immunomodulatory therapy. See Immunotherapy See also Granulomatous enteritis/colitis
Icterus, 528–530 Immunophenotyping, 587 of cats, cholelithiasis and, 162
cholelithiasis and, 163 Immunosuppression, pneumocystosis and, 793.e3 causes of, 1247
differential diagnosis of, 1243 Immunosuppressive therapy scoring systems for, 1247.e1
management of, 1430.e1a for aplastic anemia, 56 Inflammatory carcinoma, 621
Ictus. See Seizures for cutaneous lupus erythematosus, 229 Inflammatory vasculopathy, 1031.e4
Idiogenic osmoles, 498 for hepatitis, chronic idiopathic, 453–454 Influenza, canine, 545–547, 546.e1f
Idiopathic calcification, 140.e5 for histiocytic diseases, 475 infectious tracheobronchitis and, 988
Idiopathic eosinophilic bronchopneumopathy. See for immune-mediated hemolytic anemia, 62 Infraspinatus contracture, 547, 914
Eosinophilic bronchopneumopathy (EBP) for immune-mediated thrombocytopenia, 973 Infraspinatus tendon disorders, 547–548, 548f
Idiopathic gastric hypomotility, 119 for interstitial lung disease, 554 Infundibular cysts, 228.e2
Idiopathic hypertrophic cardiomyopathy. See for lymphoplasmacytic rhinitis, 891 Infundibular keratinizing acanthoma, 230–231
Hypertrophic cardiomyopathy for myasthenia gravis, 669 Inguinal hernia, 549–550
Idiopathic nodular panniculitis, 747 for pemphigus complex, 771 Inhalant medication administration, 1122–1123,
Idiopathic tremor syndrome, 530 for perianal fistula, 772 1123.e1f. See also Nebulization
Idoxuridine, for herpesviral keratitis, 465 for polymyositis, 807.e2 for bronchiectasis, 133
Ifex. See Ifosfamide for protein-losing enteropathy, 601 for feline asthma, 85
Ifosfamide, 1484 for pure red cell aplasia and nonregenerative anemia, 64 Inhalers, 693.e3
IGF–1. See Insulin-like growth factor (IGF–1) for steroid-responsive meningitis-arteritis, 942 Inherited disorders. See Hereditary defects
IGR. See Insect growth regulator (IGR) for vasculitis, 1031.e5 Injection-site reactions, 227
www.ExpertConsult.com